Response to Comments: MolDX- CDD: ProMark Risk

This document (A55305) is an administrative response to comments for MolDX - CDD: ProMark Risk and does not specify clinical coverage criteria. It records the comment period (06/13/2016–08/08/2016), the notice period (08/25/2016–10/09/2016), and that the LCD becomes final on 10/10/2016; no indications, limitations, documentation requirements for claims, or frequency limits are provided in this text.